Cytek Biosciences, Inc. ( CTKB) - Key Metrics
CTKB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.37 | -$0.09 | $0.01 | -$0.01 |
| 2026Q1 | $0.34 | -$0.15 | -$0.02 | -$0.04 |
| 2025Q4 | $0.48 | -$0.34 | -$0.01 | -$0.01 |
| 2025Q3 | $0.41 | -$0.04 | -$0.03 | -$0.04 |
| 2025Q2 | $0.36 | -$0.04 | $0 | -$0.01 |
CTKB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -12.31 |
| 2026Q1 | 0% | -7.28 |
| 2025Q4 | 0% | -3.71 |
| 2025Q3 | 0% | -20.22 |
| 2025Q2 | 0% | -19.32 |
CTKB
Price: $4.69
52 week price:
Earnings Per Share: -0.63 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 1.0 million
Market Capitalization: 605.7 million